WASHINGTON -- U.S.
Reps. Diana DeGette (D-CO), Vice Chair of the Committee on Energy and
Commerce, and Michael Castle (R-DE), both chief architects of the
recently introduced Stem Cell Research Enhancement Act of 2008 (HR 7141), sent the following letter to both presidential candidates, Senator Barack Obama and Senator John McCain, applauding
their past support for overturning President Bush’s August 2001
directive, and urging their support, from either the Senate or the
White House, for removing existing federal barriers to funding and
expansion of embryonic stem cell research, and working to put in place
an overarching ethical federal framework to guide all stem cell
research.
Text of the letter is as follows:
“It has been several years since the Stem Cell Research Enhancement Act
(H.R. 810 in the 109th Congress and H.R. 3 in the 110th Congress) was
initially written, passed, and vetoed and science has progressed at a
faster pace than we in Congress could ever have imagined. We
appreciate your support of S. 5 and are encouraged by continued
progress both in the fields of embryonic stem cell research and adult
stem cell research. In the face of fragmented state and private
research that is currently being undertaken, we also recognize the need
for strong federal leadership by the National Institutes of Health
(NIH) in carrying out a continued ethical stem cell research program in
order to realize the full potential for stem cell therapies. We are
writing to emphasize the importance of your consistent support, from
either the Senate or the White House, for removing existing federal
barriers to funding and expansion of embryonic stem cell research, and
working to put in place an overarching ethical federal framework to
guide all stem cell research.
“Looking to 2009, we recently reworked S.5 / H.R. 3 to ensure it is
current with the ever-expanding field of stem cell research and to
bring the NIH back to the forefront of stem cell research worldwide.
Our goal in introducing H.R. 7141, the “Stem Cell Research Enhancement
Act of 2008,” is to help guide the discussion over the next several
months, as we prepare for a new Congress and Administration.
“The top priority in this new legislation was to retain the integrity
and language of H.R. 3 – specifically, to expand the federal policy on
embryonic stem cell research and set forth ethical requirements. The
goal was to expand the scope of H.R. 3 to allow for NIH to establish
guidelines for carrying out all stem cell research (not just embryonic)
as scientifically warranted. With this change, the NIH will be able to
establish guidelines for the research based on scientific needs and
advances. Although numerous entities have published guidelines for
stem cell research, there is currently no overarching set of federal
guidelines to serve as the gold standard. As a result, scientists must
constantly worry about meeting a patchwork of ethical requirements.
Recognizing the link between beginning basic scientific research and
the potential for eventual clinical trials using stem cell
applications, this new legislation encourages the NIH and Food and Drug
Administration (FDA) to communicate on this important area of research.
“We have lost valuable time since the President's Directive in 2001.
With the many recent advances in stem cell techniques, it is imperative
we allow all forms to flourish; scientists, not politicians, should
decide which techniques have the best potential for progress in
developing therapies.
“Medical and scientific research, including embryonic stem cell
research, holds great promise for alleviating the suffering of the 100
million American patients who are living with devastating diseases --
from Parkinson’s disease to spinal cord injuries to diabetes -- for
which there are no good treatments or cures. A strong federal role in
carrying out such research is critical. We remain committed to driving
this issue in the next Congress and with the new Administration to form
an expanded and comprehensive federal policy for all stem cell
research.”
- McCain Letter ( 10/14/08 10:16 AM PST )
- Obama letter ( 10/14/08 10:15 AM PST )